1833 related articles for article (PubMed ID: 25476604)
1. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.
Li W; Xu H; Xiao T; Cong L; Love MI; Zhang F; Irizarry RA; Liu JS; Brown M; Liu XS
Genome Biol; 2014; 15(12):554. PubMed ID: 25476604
[TBL] [Abstract][Full Text] [Related]
2. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR.
Li W; Köster J; Xu H; Chen CH; Xiao T; Liu JS; Brown M; Liu XS
Genome Biol; 2015 Dec; 16():281. PubMed ID: 26673418
[TBL] [Abstract][Full Text] [Related]
3. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines.
Merk DJ; Paul L; Tsiami F; Hohenthanner H; Kouchesfahani GM; Haeusser LA; Walter B; Brown A; Persky NS; Root DE; Tabatabai G
Genome Med; 2024 Jun; 16(1):82. PubMed ID: 38886809
[TBL] [Abstract][Full Text] [Related]
5. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.
Meyers RM; Bryan JG; McFarland JM; Weir BA; Sizemore AE; Xu H; Dharia NV; Montgomery PG; Cowley GS; Pantel S; Goodale A; Lee Y; Ali LD; Jiang G; Lubonja R; Harrington WF; Strickland M; Wu T; Hawes DC; Zhivich VA; Wyatt MR; Kalani Z; Chang JJ; Okamoto M; Stegmaier K; Golub TR; Boehm JS; Vazquez F; Root DE; Hahn WC; Tsherniak A
Nat Genet; 2017 Dec; 49(12):1779-1784. PubMed ID: 29083409
[TBL] [Abstract][Full Text] [Related]
6. Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.
Shen H; McHale CM; Smith MT; Zhang L
Mutat Res Rev Mutat Res; 2015; 764():31-42. PubMed ID: 26041264
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute.
Wang B; Wang M; Zhang W; Xiao T; Chen CH; Wu A; Wu F; Traugh N; Wang X; Li Z; Mei S; Cui Y; Shi S; Lipp JJ; Hinterndorfer M; Zuber J; Brown M; Li W; Liu XS
Nat Protoc; 2019 Mar; 14(3):756-780. PubMed ID: 30710114
[TBL] [Abstract][Full Text] [Related]
8. De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens.
He W; Zhang L; Villarreal OD; Fu R; Bedford E; Dou J; Patel AY; Bedford MT; Shi X; Chen T; Bartholomew B; Xu H
Nat Commun; 2019 Oct; 10(1):4541. PubMed ID: 31586052
[TBL] [Abstract][Full Text] [Related]
9. A High-Resolution Genome-Wide CRISPR/Cas9 Viability Screen Reveals Structural Features and Contextual Diversity of the Human Cell-Essential Proteome.
Bertomeu T; Coulombe-Huntington J; Chatr-Aryamontri A; Bourdages KG; Coyaud E; Raught B; Xia Y; Tyers M
Mol Cell Biol; 2018 Jan; 38(1):. PubMed ID: 29038160
[TBL] [Abstract][Full Text] [Related]
10. Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform.
Esmaeili Anvar N; Lin C; Ma X; Wilson LL; Steger R; Sangree AK; Colic M; Wang SH; Doench JG; Hart T
Nat Commun; 2024 Apr; 15(1):3577. PubMed ID: 38678031
[TBL] [Abstract][Full Text] [Related]
11. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency.
Dang Y; Jia G; Choi J; Ma H; Anaya E; Ye C; Shankar P; Wu H
Genome Biol; 2015 Dec; 16():280. PubMed ID: 26671237
[TBL] [Abstract][Full Text] [Related]
12. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
[TBL] [Abstract][Full Text] [Related]
13. Protocol of CRISPR-Cas9 knockout screens for identifying ferroptosis regulators.
Yang X; Duan S; Li Z; Wang Z; Kon N; Zhang Z; Gu W
STAR Protoc; 2023 Dec; 4(4):102762. PubMed ID: 38048220
[TBL] [Abstract][Full Text] [Related]
14. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
[TBL] [Abstract][Full Text] [Related]
15. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
[TBL] [Abstract][Full Text] [Related]
16. An efficient method to generate conditional knockout cell lines for essential genes by combination of auxin-inducible degron tag and CRISPR/Cas9.
Nishimura K; Fukagawa T
Chromosome Res; 2017 Oct; 25(3-4):253-260. PubMed ID: 28589221
[TBL] [Abstract][Full Text] [Related]
17. Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells.
Guo Y; Bao C; Ma D; Cao Y; Li Y; Xie Z; Li S
ACS Synth Biol; 2019 Mar; 8(3):482-490. PubMed ID: 30762338
[TBL] [Abstract][Full Text] [Related]
18. "CRISPR" validation of recessive brain cancer genes in vivo.
Zuckermann M; Kawauchi D; Gronych J
Oncotarget; 2015 Jul; 6(20):17865-6. PubMed ID: 26203775
[No Abstract] [Full Text] [Related]
19. Large-Scale Single Guide RNA Library Construction and Use for CRISPR-Cas9-Based Genetic Screens.
Wang T; Lander ES; Sabatini DM
Cold Spring Harb Protoc; 2016 Mar; 2016(3):pdb.top086892. PubMed ID: 26933254
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation.
Wang H; Sun W
Cancer Lett; 2017 Jan; 385():137-143. PubMed ID: 27815036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
